Els Goetghebeur
Affiliations: | Applied Mathematics | Grent University |
Area:
Biostatistics, Causal inference, Quality of care, Survival analysisWebsite:
https://ai.ugent.be/people/ElsGoetghebeur.en.htmlGoogle:
"Els Goetghebeur"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ciocănea-Teodorescu I, Goetghebeur E, Waernbaum I, et al. (2023) Causal inference in survival analysis under deterministic missingness of confounders in register data. Statistics in Medicine |
| Ost P, Reynders D, Decaestecker K, et al. (2020) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial. Journal of Clinical Oncology. 38: 10-10 |
| Bruycker AD, Spiessens A, Dirix P, et al. (2020) PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. Bmc Cancer. 20: 406 |
| Sundahl N, Vandekerkhove G, Decaestecker K, et al. (2019) Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma. European Urology. 75: 707-711 |
| Vandekerkhove G, Sundahl N, Decaestecker K, et al. (2019) Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results. Journal of Clinical Oncology. 37: 422-422 |
| Ost P, Sundahl N, Vandekerkhove G, et al. (2019) Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results European Urology Supplements. 18 |
| Sundahl N, De Wolf K, Kruse V, et al. (2018) Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma. International Journal of Radiation Oncology, Biology, Physics. 100: 906-915 |
| Sundahl N, Rottey S, Decaestecker K, et al. (2018) OC-0682: Phase 1 trial of pembrolizumab with SBRT in metastatic urothelial carcinoma Radiotherapy and Oncology. 127 |
| Ost P, Reynders D, Decaestecker K, et al. (2017) Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017754853 |
| Sundahl N, De Wolf K, Rottey S, et al. (2017) A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response. Journal of Translational Medicine. 15: 150 |